Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wai-Kay Seto

Showing results (211-220 of 326) with videos related to

Pageof 33
Sort By:
Vaccines|March 30, 2023
Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 RecipientsKa Shing Cheung, Lok Ka Lam, Xianhua Mao, et al.
Hepatology (Baltimore, Md.)|March 17, 2012
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearanceWai-Kay Seto, Danny Ka-Ho Wong, James Fung, et al.
Antiviral Research|May 14, 2017
Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosomeChun Kong Chong, Ching Yan Serene Cheng, Sin Yi Jasmine Tsoi, et al.
Journal of Hepatology|March 25, 2024
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis BRyan Hin-Man Leung, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort studyTao Lyu, Ka Shing Cheung, Li Ni, et al.
Journal of Gastroenterology|March 27, 2021
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapyLung-Yi Mak, Qi Huang, Danny Ka-Ho Wong, et al.
The Journal of Infectious Diseases|May 7, 2019
Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BFen Liu, Wai-Kay Seto, Danny Ka-Ho Wong, et al.
Journal of Gastroenterology and Hepatology|February 21, 2019
Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patientsLung-Yi Mak, Michael Ko, Elvis To, et al.
Journal of Viral Hepatitis|September 9, 2024
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host ImmunityTsz-Yan Kwok, Rex Wan-Hin Hui, XianHua Mao, et al.
European Journal of Radiology|January 24, 2026
Characterising liver lesions from free-text computer tomography reports - A real-world multicentre analysisJianliang Lu, Keith Wan-Hang Chiu, Chelsea Chan, et al.
Pageof 33

Showing results (211-220 of 326) with videos related to

Sort By:
Pageof 33
Vaccines|March 30, 2023
Effect of Moderate to Severe Hepatic Steatosis on Vaccine Immunogenicity against Wild-Type and Mutant Virus and COVID-19 Infection among BNT162b2 RecipientsKa Shing Cheung, Lok Ka Lam, Xianhua Mao, et al.
Hepatology (Baltimore, Md.)|March 17, 2012
A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearanceWai-Kay Seto, Danny Ka-Ho Wong, James Fung, et al.
Antiviral Research|May 14, 2017
Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosomeChun Kong Chong, Ching Yan Serene Cheng, Sin Yi Jasmine Tsoi, et al.
Journal of Hepatology|March 25, 2024
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis BRyan Hin-Man Leung, Rex Wan-Hin Hui, Lung-Yi Mak, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort studyTao Lyu, Ka Shing Cheung, Li Ni, et al.
Journal of Gastroenterology|March 27, 2021
Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapyLung-Yi Mak, Qi Huang, Danny Ka-Ho Wong, et al.
The Journal of Infectious Diseases|May 7, 2019
Plasma Fibronectin Levels Identified via Quantitative Proteomics Profiling Predicts Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BFen Liu, Wai-Kay Seto, Danny Ka-Ho Wong, et al.
Journal of Gastroenterology and Hepatology|February 21, 2019
Serum Mac-2-binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir-treated chronic hepatitis B patientsLung-Yi Mak, Michael Ko, Elvis To, et al.
Journal of Viral Hepatitis|September 9, 2024
Cigarette Smoking Is Associated With Lower Chance of Hepatitis B Surface Antigen Seroclearance and Altered Host ImmunityTsz-Yan Kwok, Rex Wan-Hin Hui, XianHua Mao, et al.
European Journal of Radiology|January 24, 2026
Characterising liver lesions from free-text computer tomography reports - A real-world multicentre analysisJianliang Lu, Keith Wan-Hang Chiu, Chelsea Chan, et al.
Pageof 33